Duncan A. Gordon Award

THE DUNCAN A. GORDON AWARD

Honoring longtime editor of The Journal of Rheumatology, the Duncan A. Gordon Award acknowledges highly influential research articles published in The Journal based on their impact and originality, and their potential to advance treatment and alter clinical practice.

2018 WINNING ARTICLE

Defining Low Disease Activity States in Psoriatic Arthritis using Novel Composite Disease Instruments

Laura C. Coates and Philip S. Helliwell

Video: Dr. Laura C. Coates, MB, BS, MRCP, PhD, accepting the 2018 Duncan A. Gordon award on behalf of all authors, at The Journal's annual appreciation reception at the ACR 2018 conference in Chicago.

J Rheumatol February 2016; 43 (2): 371-375; published online before print December 15, 2015, doi.org/10.3899/jrheum.150826

 

2017 WINNING ARTICLE

Anti-carbamylated Protein Antibodies Are Present Prior to Rheumatoid Arthritis and Are Associated with Its Future Diagnosis

Ryan W. Gan, Leendert A. Trouw, Jing Shi, René E.M. Toes, Tom W.J. Huizinga, M. Kristen Demoruelle, Jason R. Kolfenbach, Gary O. Zerbe, Kevin D. Deane, Jess D. Edison, William R. Gilliland, Jill M. Norris, and V. Michael Holers

Video: Dr. V. Michael Holers, MD, accepting the 2017 Duncan A. Gordon award on behalf of all co-authors, at The Journal's Editorial Board reception at the ACR 2017 conference in San Diego.

J Rheumatol April 2015; 42 (4): 572-579; published online before print January 15, 2015, doi.org/10.3899/jrheum.140767

 

Fig 1. ROC curve for RAMIS synovitis at baseline and prediction of radiographic progression in the total population/RF negatives/RF positives.

2016 WINNING ARTICLE

Determining a Magnetic Resonance Imaging Inflammatory Activity Acceptable State Without Subsequent Radiographic Progression in Rheumatoid Arthritis: Results from a Followup MRI Study of 254 Patients in Clinical Remission or Low Disease Activity

Frédérique Gandjbakhch, Espen A. Haavardsholm, Philip G. Conaghan, Bo Ejbjerg, Violaine Foltz, Andrew K. Brown, Uffe Møller Døhn, Marissa Lassere, Jane E. Freeston, Inge Christoffer Olsen, Pernille Bøyesen, Paul Bird, Bruno Fautrel, Merete Lund Hetland, Paul Emery, Pierre Bourgeois, Kim Hørslev-Petersen, Tore K. Kvien, Fiona M. McQueen, and Mikkel Østergaard

J Rheumatol February 2014; 41(2):398-406; published online before print December 15, 2013, doi:10.3899/jrheum.131088

 

 

Fig 1. Ocular complications at baseline and after 12 months of treatment with IFX or ADA.2015 WINNING ARTICLE

Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry

Maria E. Zannin, Carolina Birolo, Valeria M. Gerloni, Elisabetta Miserocchi, Irene Pontikaki, Maria P. Paroli, Claudia Bracaglia, Alison Shardlow, Fulvio Parentin, Rolando Cimaz, Gabriele Simonini, Fernanda Falcini, Fabrizia Corona, Stefania Viola, Riccardo De Marco, Luciana Breda, Francesco La Torre, Fabio Vittadello, Giorgia Martini, and Francesco Zulian

J Rheumatol January 2013; 40 (1): 74-79; published online before print November 1, 2012, doi:10.3899/jrheum.120583

 

Fig 2. Comparison of pregnancy outcomes for treatment groups with history of early versus late losses.

2014 WINNING ARTICLE

Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial

Carl A. Laskin, Karen A. Spitzer, Christine A. Clark, Mark R. Crowther, Jeff S. Ginsberg, Gillian A. Hawker, John C. Kingdom, Jon Barrett, and Michael Gent

J Rheumatol February 2009; 36 (2): 279-87; published online before print February 1, 2009, doi:10.3899/jrheum.080763